These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8504016)

  • 1. Minimising the risks of PUVA treatment.
    van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
    Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-effects of psoralen photochemotherapy (PUVA).
    Wolff K
    Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP
    Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
    Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Position paper--PUVA therapy. American Academy of Dermatology.
    Bickers DR
    J Am Acad Dermatol; 1983 Feb; 8(2):265-70. PubMed ID: 6402528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B
    Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus workshop on the toxic effects of long-term PUVA therapy.
    Morison WL; Baughman RD; Day RM; Forbes PD; Hoenigsmann H; Krueger GG; Lebwohl M; Lew R; Naldi L; Parrish JA; Piepkorn M; Stern RS; Weinstein GD; Whitmore SE
    Arch Dermatol; 1998 May; 134(5):595-8. PubMed ID: 9606329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA).
    Bond CA; Grant K; Boh L
    Am J Hosp Pharm; 1981 Jul; 38(7):990-5. PubMed ID: 7020414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative UV radiation dose and outcome in clinical practice: effectiveness of trioxsalen bath PUVA with minimal UVA exposure.
    Snellman E; Rantanen T; Sundell J
    Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):207-10. PubMed ID: 11068859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).
    Nataraj AJ; Wolf P; Cerroni L; Ananthaswamy HN
    J Invest Dermatol; 1997 Aug; 109(2):238-43. PubMed ID: 9242514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative tolerability of systemic treatments for plaque-type psoriasis.
    McClure SL; Valentine J; Gordon KB
    Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer.
    van Praag MC; Bavinck JN; Bergman W; Rosendaal FR; Mommaas AM; Bruynzeel I; Scheffer E; Vermeer BJ; Bruijn JA
    J Am Acad Dermatol; 1993 Mar; 28(3):412-7. PubMed ID: 8445056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
    Kirby B; Buckley DA; Rogers S
    Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin carcinomas and treatment with photochemotherapy (PUVA).
    Lindskov R
    Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS; Bagheri S; Nichols K;
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.